BACKGROUND: Chronic kidney disease (CKD) is common, but the longitudinal effects of CKD and associated comorbidities on health care costs in the general population are unknown. METHODS: Population-based cohort study of 2,988 subjects in Germany, aged 25-74 years at baseline, who participated both in the baseline and 10-year follow-up examination (1994/95-2004/05). Presence of CKD was based on serum creatinine and defined as an estimated glomerular filtration rate of <60 ml/min/1.73 m(2). Self-reported health services utilization was used to estimate costs. RESULTS: Health care costs at baseline and follow-up were higher for subjects with CKD. Controlling for socio-economics, lifestyle factors and comorbid conditions, subjects with baseline CKD, in comparison to those without, exhibited 65% higher total costs 10 years after baseline examination, corresponding to a difference in adjusted costs of EUR 743. Incident CKD was related to 38% higher total costs. Costs for inpatient treatment and drug costs were the major costs components, while CKD revealed no effect on outpatient costs. The effect of CKD was strongly modified by angina, myocardial infarction, diabetes, and anemia. CONCLUSIONS: The direct effect of CKD on costs is modified by comorbid conditions. Therefore, early treatment of CKD and its precipitous factors may save future health care costs. 2009 S. Karger AG, Basel.
BACKGROUND:Chronic kidney disease (CKD) is common, but the longitudinal effects of CKD and associated comorbidities on health care costs in the general population are unknown. METHODS: Population-based cohort study of 2,988 subjects in Germany, aged 25-74 years at baseline, who participated both in the baseline and 10-year follow-up examination (1994/95-2004/05). Presence of CKD was based on serum creatinine and defined as an estimated glomerular filtration rate of <60 ml/min/1.73 m(2). Self-reported health services utilization was used to estimate costs. RESULTS: Health care costs at baseline and follow-up were higher for subjects with CKD. Controlling for socio-economics, lifestyle factors and comorbid conditions, subjects with baseline CKD, in comparison to those without, exhibited 65% higher total costs 10 years after baseline examination, corresponding to a difference in adjusted costs of EUR 743. Incident CKD was related to 38% higher total costs. Costs for inpatient treatment and drug costs were the major costs components, while CKD revealed no effect on outpatient costs. The effect of CKD was strongly modified by angina, myocardial infarction, diabetes, and anemia. CONCLUSIONS: The direct effect of CKD on costs is modified by comorbid conditions. Therefore, early treatment of CKD and its precipitous factors may save future health care costs. 2009 S. Karger AG, Basel.
Authors: Paul E Ronksley; Brenda R Hemmelgarn; Braden J Manns; James Wick; Matthew T James; Pietro Ravani; Robert R Quinn; Nairne Scott-Douglas; Richard Lewanczuk; Marcello Tonelli Journal: Clin J Am Soc Nephrol Date: 2016-10-06 Impact factor: 8.237
Authors: Sarah J Ramer; Nicolas A Baddour; Edward D Siew; Huzaifah Salat; Aihua Bian; Thomas G Stewart; Susan P Y Wong; Manisha Jhamb; Khaled Abdel-Kader Journal: Am J Nephrol Date: 2020-07-28 Impact factor: 3.754
Authors: Zhi Yu; Josef Coresh; Guanghao Qi; Morgan Grams; Eric Boerwinkle; Harold Snieder; Alexander Teumer; Cristian Pattaro; Anna Köttgen; Nilanjan Chatterjee; Adrienne Tin Journal: Kidney Int Date: 2020-05-23 Impact factor: 10.612
Authors: Yvette Meuleman; Lucia Ten Brinke; Arjan J Kwakernaak; Liffert Vogt; Joris I Rotmans; Willem Jan W Bos; Paul J M van der Boog; Gerjan Navis; Gert A van Montfrans; Tiny Hoekstra; Friedo W Dekker; Sandra van Dijk Journal: Int J Behav Med Date: 2015-08
Authors: Paul E Ronksley; Marcello Tonelli; Braden J Manns; Robert G Weaver; Chandra M Thomas; Jennifer M MacRae; Pietro Ravani; Robert R Quinn; Matthew T James; Richard Lewanczuk; Brenda R Hemmelgarn Journal: Clin J Am Soc Nephrol Date: 2017-01-24 Impact factor: 8.237
Authors: Taulant Muka; David Imo; Loes Jaspers; Veronica Colpani; Layal Chaker; Sven J van der Lee; Shanthi Mendis; Rajiv Chowdhury; Wichor M Bramer; Abby Falla; Raha Pazoki; Oscar H Franco Journal: Eur J Epidemiol Date: 2015-01-18 Impact factor: 8.082
Authors: Afshin Parsa; Christian Fuchsberger; Anna Köttgen; Conall M O'Seaghdha; Cristian Pattaro; Mariza de Andrade; Daniel I Chasman; Alexander Teumer; Karlhans Endlich; Matthias Olden; Ming-Huei Chen; Adrienne Tin; Young J Kim; Daniel Taliun; Man Li; Mary Feitosa; Mathias Gorski; Qiong Yang; Claudia Hundertmark; Meredith C Foster; Nicole Glazer; Aaron Isaacs; Madhumathi Rao; Albert V Smith; Jeffrey R O'Connell; Maksim Struchalin; Toshiko Tanaka; Guo Li; Shih-Jen Hwang; Elizabeth J Atkinson; Kurt Lohman; Marilyn C Cornelis; Asa Johansson; Anke Tönjes; Abbas Dehghan; Vincent Couraki; Elizabeth G Holliday; Rossella Sorice; Zoltan Kutalik; Terho Lehtimäki; Tõnu Esko; Harshal Deshmukh; Sheila Ulivi; Audrey Y Chu; Federico Murgia; Stella Trompet; Medea Imboden; Barbara Kollerits; Giorgio Pistis; Tamara B Harris; Lenore J Launer; Thor Aspelund; Gudny Eiriksdottir; Braxton D Mitchell; Eric Boerwinkle; Helena Schmidt; Edith Hofer; Frank Hu; Ayse Demirkan; Ben A Oostra; Stephen T Turner; Jingzhong Ding; Jeanette S Andrews; Barry I Freedman; Franco Giulianini; Wolfgang Koenig; Thomas Illig; Angela Döring; H-Erich Wichmann; Lina Zgaga; Tatijana Zemunik; Mladen Boban; Cosetta Minelli; Heather E Wheeler; Wilmar Igl; Ghazal Zaboli; Sarah H Wild; Alan F Wright; Harry Campbell; David Ellinghaus; Ute Nöthlings; Gunnar Jacobs; Reiner Biffar; Florian Ernst; Georg Homuth; Heyo K Kroemer; Matthias Nauck; Sylvia Stracke; Uwe Völker; Henry Völzke; Peter Kovacs; Michael Stumvoll; Reedik Mägi; Albert Hofman; Andre G Uitterlinden; Fernando Rivadeneira; Yurii S Aulchenko; Ozren Polasek; Nick Hastie; Veronique Vitart; Catherine Helmer; Jie Jin Wang; Bénédicte Stengel; Daniela Ruggiero; Sven Bergmann; Mika Kähönen; Jorma Viikari; Tiit Nikopensius; Michael Province; Helen Colhoun; Alex Doney; Antonietta Robino; Bernhard K Krämer; Laura Portas; Ian Ford; Brendan M Buckley; Martin Adam; Gian-Andri Thun; Bernhard Paulweber; Margot Haun; Cinzia Sala; Paul Mitchell; Marina Ciullo; Peter Vollenweider; Olli Raitakari; Andres Metspalu; Colin Palmer; Paolo Gasparini; Mario Pirastu; J Wouter Jukema; Nicole M Probst-Hensch; Florian Kronenberg; Daniela Toniolo; Vilmundur Gudnason; Alan R Shuldiner; Josef Coresh; Reinhold Schmidt; Luigi Ferrucci; Cornelia M van Duijn; Ingrid Borecki; Sharon L R Kardia; Yongmei Liu; Gary C Curhan; Igor Rudan; Ulf Gyllensten; James F Wilson; Andre Franke; Peter P Pramstaller; Rainer Rettig; Inga Prokopenko; Jacqueline Witteman; Caroline Hayward; Paul M Ridker; Murielle Bochud; Iris M Heid; David S Siscovick; Caroline S Fox; W Linda Kao; Carsten A Böger Journal: J Am Soc Nephrol Date: 2013-09-12 Impact factor: 10.121
Authors: Lena Dörhöfer; Alexander Lammert; Vera Krane; Mathias Gorski; Bernhard Banas; Christoph Wanner; Bernhard K Krämer; Iris M Heid; Carsten A Böger Journal: BMC Med Genet Date: 2013-02-14 Impact factor: 2.103